KRT18 and breast carcinoma: In breast cancer, KRT18 was reported to critically contribute to initiation of transforming growth factor β1 (TGF-β1)–induced epithelial–mesenchymal transition (EMT) in breast epithelial cells (Jung et al., 2016).